Market Cap (In ILA)
236.79 Million
Revenue (In ILA)
355.55 Million
Net Income (In ILA)
-61.95 Million
Avg. Volume
57.61 Thousand
- Currency
- ILA
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 440.0-1346.0
- PE
- -
- EPS
- -
- Beta Value
- 0.033
- ISIN
- IL0011063760
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Alexander Rabinovich
- Employee Count
- -
- Website
- https://www.intercure.co
- Ipo Date
- 2007-09-09
- Details
- InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
More Stocks
-
PVRINOXPVR INOX Limited
PVRINOX
-
SMARSmartphoto Group NV
SMAR
-
SANDESHThe Sandesh Limited
SANDESH
-
PTTWFOrange Polska S.A.
PTTWF
-
NEULANDLABNeuland Laboratories Limited
NEULANDLAB
-
600760
-
7297
-
002299